Kala Pharmaceuticals Receives $11,500,000 Series A Funding Round

  • Feed Type
  • Date
    3/1/2013
  • Company Name
    Kala Pharmaceuticals
  • Mailing Address
    135 Beaver St. Waltham, MA 02452
  • Company Description
    Kala Pharmaceuticals, Inc. is a biotechnology company founded upon a proprietary drug delivery technology. By utilizing this unique technology, Kala aims to address unmet therapeutic needs of various diseases and conditions in a fundamentally novel way.
  • Website
    http://www.kalarx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to advance a portfolio of innovative ophthalmic programs based on Kala’s Mucosal Penetrating Product (MPP) platform through clinical proof of concept.
  • M&A Terms
  • Venture Investor
    Crown Venture Fund
  • Venture Investor
    Lux Capital
  • Venture Investor
    Polaris Partners
  • Venture Investor
    Third Rock Ventures